Login to Your Account



NewCo News: EpiTherapeutics Leveraging Epigenetics Against Cancer

By Marie Powers


Friday, May 6, 2011
EpiTherapeutics ApS is a little company with big plans. Last December, the Copenhagen, Denmark-based firm inked its first drug discovery agreement with Abbott, of Abbott Park, Ill., to develop cancer drugs by making small-molecule inhibitors against selected epigenetic oncology targets.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription